Research Article
Comparison of Enoxaparin and Rivaroxaban in the Prophylaxis of Deep Venous Thrombosis in Arthroplasty
Table 1
Distribution of major complications
| Major complications | | Group 1 (46) | Group 2 (123) | Group 3 (45) | Total (214) |
| Bleeding causing a decrease in the amount of Hb more than 2 g/dl | 10 | 5 (11.1%) | 5 (4%) | 0 | 10 (4.6%) |
| Bleeding causing more than two units of blood transfusion | 16 | 0 | 10 (8.13%) | 6 (13%) | 16 (7.4%) |
| Bleeding causing treatment discontinuation or requiring reoperation for bleeding control | 0 | 0 | 0 | 0 | 0 |
| Symptomatic retroperitoneal, intracranial, intraocular, or intraspinal bleeding | 0 | 0 | 0 | 0 | 0 |
| Fatal bleeding | 0 | 0 | 0 | 0 | 0 |
| Total | 26 | 5 (2.3%) | 15 (7%) | 6 (2.8%) | 26 (23%) |
|
|